Liver Cancer (M.D. Anderson Solid Tumor Oncology Series) (Hardcover)

~ Steven A. Curley (Editor) "Surgical techniques with curative intent are becoming more common-place for both primary and metastatic tumors of the liver..." (more)
Key Phrases: perihilar tumors, hepatic venous isolation, functional hepatic reserve, Ann Surg, Arch Surg, Surg Oncol (more...)

Editorial Reviews

Product Description

Liver Cancer, the inaugural volume in the M.D. Anderson Solid Tumor Oncology series, provides the general surgeon, surgical oncologist, and medical oncologist with the most up-to-date and current standard of multimodality care for hepatobiliary cancer. Surgical approaches, chemotherapy, immunotherapy, gene therapy, and radiotherapy are all presented, giving the practitioner a much needed, comprehensive perspective on all aspects of patient care.

The MD Anderson Solid Tumor Oncology series features cutting-edge, in-depth information of vital interest to all practitioners in today's captitated financial milieu. Providers must understand how their component of care interdigitates with the varied medical and surgical teams and apply multimodality approaches to their practice environments.

Product Details

• Hardcover: 253 pages
• Publisher: Springer; 1 edition (June 26, 1998)
• Language: English
• ISBN-10: 0387983708
• ISBN-13: 978-0387983707
• Product Dimensions: 9.2 x 6 x 0.7 inches
• Shipping Weight: 1.3 pounds (View shipping rates and policies)
• Average Customer Review: 3.0 out of 5 stars  See all reviews (1 customer review)
• Amazon.com Sales Rank: #2,530,735 in Books (See Bestsellers in Books)

  Popular in this category: (What's this?)

  #67 in

  Books > Science > Medicine > Diseases > Digestive Organs

Customer Reviews

Most Helpful Customer Reviews

1 of 1 people found the following review helpful:

3.0 out of 5 stars "If you get Liver Cancer, you are going to die.", July 30, 2007

By	Fred Mrozek (German Valley, Illinois United States) - See all my reviews (REAL NAME)

When a former co-worker got liver cancer, I bought this book for several reasons, one of which was a search for the best treatments - or, more simply put, for hope. If that is what you are looking for, and nothing else, then skip this book. If, on the other hand, you want essential background to the disease, and can use this background to help negotiate the complex considerations of new chemotherapeutic agents, then this book is recommended.

This field is changing rapidly. Not rapidly enough as it turns out, but it seems only a matter of time before a cluster of genetic insights converge and treating such cancers becomes a practical reality. To the researchers doing such work, Godspeed.